CMS’ mandatory GLOBE drug model ties some Medicare Part B rebates to global prices, but cuts projected savings sharply amid ...

In this discussion, Ohio State economist Eric Seiber, Ph.D., explains how inconsistent claims-data definitions can skew ...

State PBM reform accelerates through 2026, with Theresa Carnegie of Mintz unpacking new laws, rebate pass-through, spread ...

Some predicted that drugmakers might boost launch prices to make up for Medicare drug negotiations shrinking profits. Harvard ...

Fewer than one in five young people with first episode psychosis filled enough antipsychotic prescriptions to be considered ...

Tariffs on patented drugs broaden beyond Big Pharma, and exemptions, MFN deals and origin caps determine rates and potential ...

Moving the 340B program from upfront discounts to a rebate model would add work for health systems but likely wouldn't change the picture for employers and other plan sponsors, ac ...

Teledentistry has become an important tool for helping patients access dental expertise when and where they need it. It can ...

Medication price comparisons remain opaque because multiple price definitions exist and patients typically learn ...

Employers that decide to stop covering GLP-1s for weight loss are increasingly pairing that decision with support for the ...

National Alliance of Healthcare Purchaser Coalitions (National Alliance) has named Jenny Goins its interim president and CEO ...

Just two therapies are available to treat MASH. The first was Madrigal Pharmaceuticals’ Rezdiffra (resmetirom), which was ...